Skip to main content
OpenTrials

Clinical trial condition

Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder

Explore clinical trials studying Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder trial results

Recruiting

Epcoritamab for the Treatment of Relapsed or Refractory Post Transplant Lymphoproliferative Disorders

NCT06672705

Conditions
Diffuse Large B-Cell Lymphoma Post-Transplant Lymphoproliferative Disorder, EBV-Related Post-Transplant Lymphoproliferative Disorder, Recurrent Monomorphic Post-Transplant Lymphoproliferative Disorder, +3 more
Locations
  • Washington University St Louis, Missouri, United States
  • Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
View Trial Details

Related conditions